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kept 'on the go' by being topped up, whether the appara-
tus was cleansed daily, weekly or hardly ever. and how it
was cleaned. Mixing utensils were examined.
Medication given to the infant was inve tigated, parti-
cularly that administered within the previous 2 week . as
to whether it was obtained from a clinic, medical prac-
titioner, shop, herbalist or witchdoctor, and the type of
medicine, whether laxatives or enemas were given and
how often, on what occasion and of what type. Dummies
were tudied. Information was obtained as to whether
mother, grandmother or children looked after the infant,
their state of intelligence and cleanliness and their commit-
ment to other duties, bearing in mind such unusual cir-
cumstances in the Bantu areas as the reversion of an
infant to an often disinterested maternal grandmother be-
cause the husband had failed to pay lobola, which tradi-
tionally gives him the right to the womb and its issue.
Field investigators were requested to record any addi-
tional pertinent factors encountered.
Control group. Randomly-selected well babies were
used for control purposes. In the Bantu areas the fir t 10
clinically normal babies, or a les er number to parallel
the sample group, who presented at the child health
promotive and preventive clinics of the 5 poly-clinic
conducting the field study were selected on each day on
which sample cases were drawn. The e control case were
submitted to exactly the ame clinical. domiciliary and
laboratory investigations as the sample cases.
(To be continued)
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Patients with mitral valve prostheses are usually advised
against becoming pregnant. These patients are usually
maintained on long-term anticoagulation therapy which,
hould pregnancy occur, may pose difficult problems for
the patient, the foetus and the physician.
VillaSanta' and Beller' outlined the dangers to the preg-
nant patient who is maintained on anticoagulant therapy.
Bennett and Oakley' reported the death after caesarean
ection of the mother in whom a Hammersmith-Alvarez
mitral prosthesis had been inserted before pregnancy, and
advised sterilization in such instances.
We report here a successful pregnancy with delivery of
a normal child in a primigravida, with a University of
telJenbosch mitral valve prosthesis, in whom anticoagu-
lation therapy was not used.
We believe that in selected cases where the pregnancy
is highly desirable these patients should be granted the
opportunity to continue with the pregnancy in the light of
the improved results now being obtained with the newer
design of prosthetic heart valve.
CASE REPORT
The patient was a 17-year-old Bantu woman who had had
rheumatic fever at tbe age of 14 years. At the age of 16
years he developed severe heart failure and pulmonary
oedema due to mitral incompetence that was confirmed by
cardiac catheterization studies. These studies also showed
the presence of minimal aortic incompetence.
She initially responded well to medical therapy but
12 month!; later deteriorated and was thought to have
ubacute bacterial endocarditis. Although repeated blood
cultures were negative, the sedimentation rate remained
elevated. and he was treated for bacterial endocarditi .
Conge tive heart failure persisted and her mitral valve
'Date received: 9 September 1969.
was replaced with a 20-mm. University of Stellenbosch
mitral valve prosthesis (Fig. I). at Karl Bremer Ho pital
on 6 December 1967.
She made a remarkable recovery and was discharged 4
weeks after the operation. Anticoagulation with warfarin
sodium had been started on the third po toperative day.
and it was decided to continue the oral anticoagulation
for a period of 3 months. Her medications at the time of
discharge included digitoxin. 0·1 mg. b.d., and warfarin
sodium, 2·5 mg. daily.
However, she discontinued all medications of her own
accord one month after discharge and failed to report to
her local physician at Barkly East. She was married with-
in a year after her operation and fir t consulted her
physician at 24 weeks' gestation. The pregnancy wa
normal in all respects, without any signs of cardiac failure,
and it was decided not to use anticoagulation therapy at
that stage. Urinalysis revealed the presence of a urinary
tract infection which responded well to antibiotic therapy.
The progress of the pregnancy was uncomplicated, and
she was hospitalized at the Cloete-Joubert Hospital in
Barkly East on 25 May 1969. On 26 May she was de-
livered of a normal 7-lb. baby at term without any com-
plications. She breast fed the child. and they were dis-
charged on the fifth day after delivery. Mother and child
continue to do well more than 3 months after delivery.
DISCUSSIO
This i the eventh report of pregnancy in a patient who
had undergone prosthetic mitral valve replacement before
pregnancy. Although the first report by Johnson et al"
was encouraging, DiSaia' and Kerber et al" reported con-
genital malformation of the infants in the form of saddle-
nose deformity. bilateral optic atrophy and mental retar-
dation that was attributed to the u e of warfarin odium
during pregnancy. Bennett and Oakley' reported multiple
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niversity of Stellenbosch cloth-covered. disc
pro thesis.
systemic emboli and the death of the mother In the
postpartum period due to thrombus formation on the
prosthe i .
These reports gave cause for concern and re ulted in
a policy of advising patients with pro thetic mitral valves
to avoid pregnancy or to undergo sterilization'
More recently Bloomfield and Rubinstein' reported a
ucce ful pregnanc and delivery of a normal infant in
a patient with a Starr-Edwards mitral valve prosthesis.
The patient took warfarin sodium for 36 weeks and was
given heparin parenterally for 18 days before delivery.
They believe successful pregnancy and delivery in patients
with mitral valve prostheses is possible when careful
control of anticoagulation is maintained.
Finnerty and MacKay and Aaro et al.' also reported
that, when properly used. oral anticoagulation therapy was
both safe aMd effective during pregnancy.
The use of anticoagulation during pregnancy can
nevertheless be potentially hazardous, as oral anticoagu-
lants cross the placental barrier with depression of the
prothrombin content of the foetal blood.]· Besides mal-
formation of the foetus, fatal haemorrhage of tbe bypo-
thrombinaemic foetus or newborn occurred when the
limits of the therapeutic range were exceeded or when the
oral anticoagulant was not discontinued long enough
before labour.7,B
VilJaSanta' reviewed 92 cases of pregnant patients re-
ported in the literature, who were treated with oral anti-
coagulants alone or in conjunction with heparin. In these
patients, there were 14 stiJJborn infants and 3 neonatal
deaths, representing a perinatal mortality of 18'4% or al-
most 1 in 5 cases. Furthermore, there were 2 other infants
with congenital anomalies related to defect of coagulation,
who lived, but with residua.
Ideally, pregnant patients with prosthetic valves should
not receive anticoagulant therapy. This, however, should
be weighed against the potential danger of systemic embo-
lism or thrombotic obstruction of the prosthetic valve.
The use of the newer types of prosthetic mitral valves,
with cloth covering and subsequent tissue ingrowth into
the prosthesis,"-H has markedly lowered the incidence of
thrombo-embolism. Following our previously reported ex-
perimental studies in subhuman primates and initial clini-
cal experience," we now use warfarin sodium only during
the first 3 - 6 postoperative months. We have detected no
late systemic emboli or cases of thrombosis with the Uni-
versity of Stellenbosch mitral valve prosthesis for periods
of 3 months to 2 years after valve insertion where anti-
coagulant therapy has been discontinued. We therefore
feel justified to continue thi policy also during preg-
nancy, so as to avoid the potential hazards of oral or
parenteral anticoagulation therapy.
SUMMARY
An uncomplicated pregnancy is reported in a l7-year-old
female with a University of Stellenbosch mitral valve pros-
thesis following rheumatic heart disease and subacute bacterial
endocarditis. The patient received no anticoagulant therapy
during pregnancy and delivered a normal, healthy 7-lb. baby.
Successful pregnancy and delivery in patients with a University
of Stellenbo ch mitral valve prosthesis is possible without the
use of anticoagulation. This is believed to be the first reported
case of a normal pregnancy and delivery of a normal infant
following mitral valve replacement and discontinuation of
anticoagulation therapy.
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